# Janssen Biotech, Inc. – FDA Inspection, Nov 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/2f697eb7-fa9a-4da8-b845-2d83b13b09f0
Source feed: FDA_Inspections

> FDA inspection 1031776 of Janssen Biotech, Inc., November 21, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031776
- Company Name: Janssen Biotech, Inc.
- Inspection Date: 2017-11-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1276933 - 2025-07-29](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/0ecc31ca-e799-4909-bfc9-dcdfa484fbf5)
- FDA Inspection 1265723 - 2025-03-10
- FDA Inspection 1077487 - 2018-11-30
- [FDA Inspection 1046499 - 2018-03-05](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/4135886d-b271-492a-8b05-81d78eba721b)
- FDA Inspection 1027122 - 2017-09-22

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c